New FDA-Approved Treatment for Obesity | Leonard Pianko MD, Aventura Cardiovascular Center

In the U.S., more than 100 million adults - about one in three - are obese.
A popular diabetes medication semaglutide (Ozembic)* has now been approved by the FDA for weight loss.
Given at a higher dose and renamed Wegovy [, this drug is given by injection weekly for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.
The drug is a synthetic version of a gut hormone that suppresses hunger and appetite.
In clinical trials, participants who took the medication lost about 12 percent of their body weight compared to those who took a placebo.
"This is the first drug the FDA has approved for weight loss since 2014," explained Aventura Cardiologist Leonard Pianko MD to WPLG Channel 10 News Reporter, Kristi Krueger. "Those who took Wegovy lost weight steadily for 16 months before plateauing and I am pleased to be offering this new drug to my patients."
For more information about Wegovy, visit our website www.leonardpiankomd.com and follow us on Facebook and LinkedIn.
And don't forget to LIKE, COMMENT, and SHARE this video.
#wegovy
#weightloss
#aventuracardiologist

[@delwoodkelp8590]

Credibility...?